Actively Recruiting
Supportive Care Intervention Development to Address Employment Concerns After Allogeneic Hematopoietic Stem Cell Transplantation
Led by MGH Institute of Health Professions · Updated on 2025-12-19
35
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
MGH Institute of Health Professions
Lead Sponsor
M
Massachusetts General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a Work Support (WorkS) intervention aimed at helping people who have undergone allogeneic stem cell transplantation and are preparing to return to work. This study focuses on assessing the feasibility and acceptability of the WorkS program and study procedures. It also explores early effects on patients' confidence in returning to work, their employment status, quality of life, and financial challenges. Participants who received an allogeneic hematopoietic stem cell transplant within the past six months and have concerns about returning to work will take part in this single-group study. The WorkS intervention involves two structured sessions within two months, starting about six months after the transplant. These sessions help identify work-related challenges, connect participants to supportive resources, and facilitate communication with employers to arrange necessary work modifications. The study lasts about six months per participant, including baseline assessments soon after enrollment, the two WorkS sessions, and exit assessments shortly after the last session. A final follow-up on work status is done at 12 months post-transplant. Researchers will track rates of screening, eligibility, enrollment, intervention completion, and assessments. They will also evaluate work status, financial concerns, quality of life, and return-to-work confidence to understand the intervention's impact.
CONDITIONS
Brief Title
Employment Support After Hematopoietic Stem Cell Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Received an allogeneic hematopoietic stem cell transplant within the past six months to treat a blood cancer
- Screen positive for work-related concerns by answering "yes" to being worried about returning to work in the next six months
- Adults aged 18 to 70 years
- Able to provide informed consent and participate in study procedures
You will not qualify if you...
- Having acute psychiatric or cognitive conditions that prevent informed consent or study compliance
- Unable to provide consent
- Not an adult
- Pregnant women
- Prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 weeks
Participants enroll approximately six months after their stem cell transplant and complete a baseline assessment.
1 visit (in-person)
Duration - Within 2 months
Participants complete two structured Work Support (WorkS) appointments focused on addressing work-related challenges and connecting with resources.
2 visits (in-person) approximately 1 month apart within a 2-month window
Duration - Up to 3 weeks
Participants complete an exit assessment shortly after the final Work Support appointment.
1 visit (in-person)
Duration - 1 visit within a 6-week window around 12 months post-transplant
Participants report their return to work status at 12 months post-transplant.
1 visit (in-person or remote)
Trial Site Locations
Total: 1 location
1
MGH Cancer Center
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
K
Kathleen Lyons, ScD, OTR/L
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here